Results 101 to 110 of about 28,065 (211)

Efficacy Of Artemether In Attenuating Spontaneous Intracerebral Hemorrhage [PDF]

, 2018
Spontaneous Intracerebral Hemorrhage (ICH) is a debilitating form of stroke that most commonly emerges from dysfunction of brain interendothelial junction proteins.
Hassanpour, Arman
core  

The effects of artemether, shRNA-VCAM-1 and artemether combined with shRNA-VCAM-1 on the enzymatic activity of MMP-2/9.

, 2013
Enzymatic activity of MMP-2/9 under the treatments of artemether (300 µmol/L), shRNA-VCAM-1 and artemether combined with shRNA-VCAM-1 was investigated by fluorescently quenched gelatin assay.
Yi Hu (58993), Yi-Xue Xue (321473), Ying-Bin Wang (101805), Yun-Hui Liu (401748), Ping Wang (42415), Yi-Long Yao (401747), Bo Yu (241082), Zhen Li (49109)   +7 more
core   +1 more source

Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults.

, 2016
OBJECTIVES: Co-administration of artemether/lumefantrine with antiretroviral therapy has potential for pharmacokinetic drug interactions. We investigated drug-drug interactions between artemether/lumefantrine and efavirenz or nevirapine.

core   +1 more source

Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial.

, 2013
BACKGROUND: Artemisinin-based combination therapy (ACT) reduces the potential for malaria transmission, compared with non-ACTs. It is unclear whether this effect differs between ACTs.
Sauerwein, Robert W, Drakeley, Chris J, Bousema, Teun, Kavishe, R.A., Kavishe, Reginald A, Hallett, Rachel L, Mweresa, Collins K, Hermsen, C.C., Sauerwein, R.W., Shekalaghe, S., Manjurano, Alphaxard, Omar, S.A., Shekalaghe, Seif A., Sawa, Patrick, Sutherland, Colin J, Baidjoe, Amrish Y, Yussuf, R.U., Mweresa, C.K., Omar, Sabah A., Okell, L., Okell, Lucy, Hermsen, Cornelus C., Schallig, Henk DFH, Bousema, T., Manjurano, A., Baidjoe, A.Y., Mweresa, Collins K., Hallett, R.L., Beshir, Khalid B., Beshir, Khalid B, Shekalaghe, Seif A, Beshir, K.B., Drakeley, Chris J., Kavishe, Reginald A., Omar, Sabah A, Sutherland, Colin J., Yussuf, Rahma U, Sawa, P., Baidjoe, Amrish Y., Schallig, H.D., Yussuf, Rahma U., Drakeley, C., Hermsen, Cornelus C, Sutherland, C.J., Sauerwein, Robert W., Hallett, Rachel L., Schallig, Henk D.F.H.   +46 more
core   +1 more source

Preparation of artemether hapten and protein-hapten conjugate.

, 2013
Preparation of artemether hapten and protein-hapten conjugate.
Liwang Cui (82978), Zhen Cao (30837), Wei Zhang (405), Guiyu Tan (484227), Yongliang Cui (484225), Rui Zhang (13940), Suqin Guo (484224), Lishan He (484226), Liang Zhang (41392), Baomin Wang (174006)   +9 more
core   +1 more source

Resistance to Dihydroartemisinin

Emerging Infectious Diseases, 2007
Sandrine Cojean, Véronique Hubert, Jacques Le Bras, Rémy Durand, Eric Legrand, Beatrice Volney, Jean-Baptiste Meynard, Philippe Esterre, Odile Mercereau-Puijalon   +8 more
doaj   +1 more source

Artemether-lumefantrine for treating uncomplicated falciparum malaria.

, 2003
BACKGROUND: Artemether-lumefantrine is being promoted by the World Health Organization for treating uncomplicated malaria. It is expensive. We sought evidence of its superiority over existing treatment regimens.
Omari, A. A., Gamble, Carrol, Garner, P.; id_orcid   +2 more
core   +1 more source

Enhanced in vivo antimalarial activity of artemether by clotrimazole against drug-sensitive and resistant Plasmodium berghei [PDF]

The emergence of resistance parasites to currently approved artemisinin-based combination therapies (ACTs) highlight the need for regimens incorporating repurposed antimalarials.
Ugwuoke , Wilfred I., Nweke , Linda C., Kenechukwu , Franklin C., Okachi , Joshua C., Attama , Anthony A., Ogbonna , Jude E., Odo, Bonaventure A., Momoh , Mumuni A., Nnamani , Daniel O., Nzekwe , Ezichim F., Odoh , Tochukwu, Nwagwu , Chinekwu S., Obila , Mary U., Nwobodo , Joy I., Anikwe , Celestine C.   +14 more
core   +1 more source

Lack of activity of artemether for prophylaxis and treatment of

, 2014
Artemisinin and its derivatives have been found effective in vivo against Plasmodium and in vitro against Toxoplasma gondii and Pneumocystis carinii.
P. M. Girard, F. Derouin, F. Chau, M. Brun-Pascaud   +3 more
core   +1 more source

Antimalarial Drug Repurposing of Epirubicin and Pelitinib in Combination with Artemether and Lumefantrine

Pharmaceuticals
Background: Drug therapy remains the principal management strategy for malaria but is increasingly challenged by the emergence of drug-resistant malaria parasites.
Douglas O. Ochora, Reagan M. Mogire, Bernard M. Murithi, Farid Abdi, Erick N. Ondari, Rael J. Masai, Edwin Mwakio, Agnes Cheruyiot, Abiy Yenesew, Hoseah M. Akala   +9 more
doaj   +1 more source